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Background: The power of HbA1c to predict future cardiovascular events in the clinically important high-risk population of patients undergoing 
coronary angiography has not been investigated so far. In the present study we therefore addressed this issue and also tested the hypothesis that 
gender modulates the impact of HbA1c on cardiovascular event risk.
methods: We prospectively recorded cardiovascular events over a mean follow-up period of 4.4 years in a large consecutive series of 1449 
patients, including 484 women and 965 men who did not have previously known diabetes and who underwent coronary angiography for the 
evaluation of stable coronary artery disease.
results: During follow-up, the incidence of cardiovascular events was 19.5% in women and 25.6% in men, corresponding to annual event rates 
of 4.4% and 5.8%; p = 0.001. Among women, HbA1c strongly and significantly predicted cardiovascular events (adjusted OR for a 1% increase 
in HbA1c = 1.69 [1.16-2.45]; p = 0.006), whereas the association between HbA1c and cardiovascular events was weaker and statistically non-
significant in men (OR = 1.15 [0.95-1.39]; p = 0.147. An interaction term gender x HbA1c was significant (p = 0.024), indicating that HbA1c was a 
significantly stronger predictor of cardiovascular events among women than among men.
conclusions: We conclude that HbA1c is a significantly stronger predictor of cardiovascular event risk in women than in men among patients 
undergoing coronary angiography.
